| 1 | Inflammatory spindle cell PEComa of the lung with YAP1::TFE3 fusion: a report of two cases and a potential relationship with clear cell stromal tumour | 2.6 | 9 | Citations (PDF) |
| 2 | Data set for the reporting of lung cancer: recommendations from the International Collaboration on Cancer Reporting (ICCR) | 2.6 | 1 | Citations (PDF) |
| 3 | Radiologists Versus AI-Based Software: Predicting Lymph Node Metastasis and Prognosis in Lung Adenocarcinoma From CT Under Various Image Display Conditions | 2.1 | 2 | Citations (PDF) |
| 4 | WEE1 confers resistance to KRASG12C inhibitors in non-small cell lung cancer | 6.5 | 9 | Citations (PDF) |
| 5 | Asian Thoracic Oncology Research Group expert consensus statement on the peri-operative management of non-small cell lung cancer | 1.8 | 9 | Citations (PDF) |
| 6 | Schlafen 11 Expression in Patients With Small Cell Lung Cancer and Its Association With Clinical Outcomes | 1.5 | 6 | Citations (PDF) |
| 7 | EGFR mutation testing across the osimertinib clinical program | 1.8 | 4 | Citations (PDF) |
| 8 | Upfront liquid biopsy in patients with advanced solid tumors who were not feasible for tissue-based next-generation sequencing | 1.3 | 1 | Citations (PDF) |
| 9 | Clinicopathological and molecular characterization of KRAS wild‐type pancreatic ductal adenocarcinomas reveals precursor lesions with oncogenic mutations and fusions in RAS pathway genes | 3.2 | 5 | Citations (PDF) |
| 10 | Proposal for a New Classification of Rare Cancers Adopting Updated Histological Tumor Types | 0.8 | 5 | Citations (PDF) |
| 11 | Is segmentectomy actually superior to lobectomy for early-stage lung cancer? A discrepancy between the JCOG0802 trial and real-world practice | 1.1 | 1 | Citations (PDF) |
| 12 | Prediction recurrence in stage I epidermal growth factor receptor-mutated non-small cell lung cancer using multi-modal data | 1.8 | 2 | Citations (PDF) |
| 13 | Flat Cell Variant of Lung Adenocarcinoma In Situ | 3.8 | 0 | Citations (PDF) |
| 14 | Rare but clinically important salivary gland-type tumor of the lung: A review | 1.3 | 8 | Citations (PDF) |
| 15 | Molecular pathology of non‐small cell carcinoma | 2.6 | 25 | Citations (PDF) |
| 16 | Optimizing tissue stewardship in non‐small cell lung cancer to support molecular characterization and treatment selection: statement from a working group of thoracic pathologists | 2.6 | 21 | Citations (PDF) |
| 17 | Is 18F-fluorodeoxyglucose PET recommended for small lung nodules? CT findings of 18F-fluorodeoxyglucose non-avid lung cancer | 1.9 | 2 | Citations (PDF) |
| 18 | Oncological feasibility of segmentectomy for inner-located lung cancer | 1.1 | 10 | Citations (PDF) |
| 19 | Advances in cancer DNA methylation analysis with methPLIER: use of non-negative matrix factorization and knowledge-based constraints to enhance biological interpretability | 9.5 | 7 | Citations (PDF) |
| 20 | Retinal gliosis with osseous metaplasia in an infant | 0.8 | 0 | Citations (PDF) |
| 21 | Pro: “Is Spread Through Air Spaces an In Vivo Phenomenon or an Inducible Artifact?” | 1.5 | 10 | Citations (PDF) |
| 22 | Clinical and Pathologic Differences between Small-Cell Carcinoma and Large-Cell Neuroendocrine Carcinoma of the Lung | 1.7 | 3 | Citations (PDF) |
| 23 | GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathway | 5.2 | 7 | Citations (PDF) |
| 24 | Assessment of the Pathologic Response to Neoadjuvant Therapy | 0.1 | 0 | Citations (PDF) |
| 25 | Leveraging non‐coding regions to guarantee the accuracy of small‐sized panel‐based tumor mutational burden estimates | 2.9 | 2 | Citations (PDF) |
| 26 | Sporadic and Familial Adenomatous Polyposis-associated Foveolar-type Adenoma of the Stomach | 2.3 | 21 | Citations (PDF) |
| 27 | Radiological precursor lesions of lung squamous cell carcinoma: Early progression patterns and divergent volume doubling time between hilar and peripheral zones | 1.8 | 10 | Citations (PDF) |
| 28 | Feasibility and effectiveness of segmentectomy versus wedge resection for clinical stage I non-small-cell lung cancer | 1.2 | 32 | Citations (PDF) |
| 29 | Real‐world study of next‐generation sequencing diagnostic biomarker testing for patients with lung cancer in Japan | 2.9 | 15 | Citations (PDF) |
| 30 | KLF4 c.A1322C Mutation Is a Consistent and Specific Genetic Feature of Raspberry-like Foveolar-type Adenoma of the Stomach | 2.3 | 7 | Citations (PDF) |
| 31 | Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2–IA3 EGFR-Mutated NSCLC: ADAURA2 | 2.1 | 67 | Citations (PDF) |
| 32 | Keratin‐positive fibrotic extraskeletal myxoid chondrosarcoma: a close mimic of myoepithelial tumour | 2.6 | 7 | Citations (PDF) |
| 33 | Impact of age for overall survival in head and neck sarcoma | 1.0 | 2 | Citations (PDF) |
| 34 | Molecular pathology quality control in Southeast Asia: Results of a multiregional quality assurance study from MASTER KEY Asia | 2.9 | 10 | Citations (PDF) |
| 35 | Reply to the Letter to the Editor From He Y et al | 1.5 | 1 | Citations (PDF) |
| 36 | Role of fluorine-18-fluorodeoxyglucose positron emission tomography in selecting candidates for a minimally invasive approach for thymic epithelial tumour resection 2023, 36, | | 2 | Citations (PDF) |
| 37 | KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testing | 1.8 | 116 | Citations (PDF) |
| 38 | A comprehensive appraisal of HER2 heterogeneity in HER2-amplified and HER2-low colorectal cancer | 4.1 | 15 | Citations (PDF) |
| 39 | Impact of 18F-FDG PET on TNM Staging and Prognosis in Thymic Epithelial Tumors | 1.7 | 4 | Citations (PDF) |
| 40 | Strategic Approach to Heterogeneity Analysis of Cutaneous Adnexal Carcinomas Using Computational Pathology and Genomics | 1.6 | 3 | Citations (PDF) |
| 41 | Promoter swapping of truncated PDGFRB drives Ph-like acute lymphoblastic leukemia | 4.9 | 5 | Citations (PDF) |
| 42 | Whole-genome sequencing reveals the molecular implications of the stepwise progression of lung adenocarcinoma | 10.8 | 59 | Citations (PDF) |
| 43 | VIII．肺癌の病理診断 | 0.0 | 0 | Citations (PDF) |
| 44 | Maximum standardized uptake value of the primary tumor does not improve candidate selection for sublobar resection | 2.2 | 7 | Citations (PDF) |
| 45 | SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1–Negative Lung Adenocarcinomas | 3.2 | 47 | Citations (PDF) |
| 46 | Clinical usefulness of PET/MRI in differentiating anterior mediastinal masses | 0.8 | 4 | Citations (PDF) |
| 47 | Prognostic Impact of the Histologic Lepidic Component in Pathologic Stage IA Adenocarcinoma | 1.5 | 34 | Citations (PDF) |
| 48 | The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015 | 1.5 | 1,392 | Citations (PDF) |
| 49 | A mimic of lung adenocarcinoma: a case report of histological conversion of metastatic thyroid papillary carcinoma | 2.6 | 2 | Citations (PDF) |
| 50 | Assessment of Resectability of Mediastinal Germ Cell Tumor Using Preoperative Computed Tomography | 1.0 | 1 | Citations (PDF) |
| 51 | Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments | 28.4 | 836 | Citations (PDF) |
| 52 | Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors | 2.7 | 22 | Citations (PDF) |
| 53 | Clinicopathologic and Genotypic Features of Lung Adenocarcinoma Characterized by the International Association for the Study of Lung Cancer Grading System | 1.5 | 95 | Citations (PDF) |
| 54 | Activating KRAS and GNAS mutations in heterotopic submucosal glands of the stomach | 3.0 | 8 | Citations (PDF) |
| 55 | Updates in the 5th Edition of the WHO Classification of Thoracic Tumors | 0.1 | 1 | Citations (PDF) |
| 56 | NSCLC Subtyping in Conventional Cytology: Results of the International Association for the Study of Lung Cancer Cytology Working Group Survey to Determine Specific Cytomorphologic Criteria for Adenocarcinoma and Squamous Cell Carcinoma | 1.5 | 27 | Citations (PDF) |
| 57 | Rapidly progressing metastatic malignant melanoma mimicking primary pleural tumor: A case report | 1.5 | 2 | Citations (PDF) |
| 58 | Role of Image-Guided Percutaneous Needle Biopsy in the Age of Precision Medicine | 2.8 | 4 | Citations (PDF) |
| 59 | Comparative Study on the Efficacy and Exposure of Molecular Target Agents in Non–small Cell Lung Cancer PDX Models with Driver Genetic Alterations | 1.2 | 8 | Citations (PDF) |
| 60 | Co-expression of ERG and CD31 in a subset of CIC-rearranged sarcoma: a potential diagnostic pitfall | 3.8 | 28 | Citations (PDF) |
| 61 | Liposarcoma With Hibernoma-like Histology | 2.3 | 5 | Citations (PDF) |
| 62 | Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer | 4.1 | 15 | Citations (PDF) |
| 63 | Invasive Mucinous Adenocarcinoma of the Lung With a Mural Nodule-like Lesion | 2.3 | 3 | Citations (PDF) |
| 64 | Aggressive histological component in subsolid lung adenocarcinoma: priority for resection without delay | 1.3 | 0 | Citations (PDF) |
| 65 | 2021 WHO Classification of Lung Cancer: A Globally Applicable and Molecular Biomarker-Relevant Classification | 1.5 | 19 | Citations (PDF) |
| 66 | Long-Term Prognosis and Prognostic Indicators of Stage IA Lung Adenocarcinoma | 1.7 | 7 | Citations (PDF) |
| 67 | Insulinoma-associated-1 (INSM1) expression in thymic squamous cell carcinoma | 1.9 | 13 | Citations (PDF) |
| 68 | Consistency and prognostic value of preoperative staging and postoperative pathological staging using 18F-FDG PET/MRI in patients with non-small cell lung cancer | 1.4 | 8 | Citations (PDF) |
| 69 | Visualization of patterns of lymph node metastases in non–small cell lung cancer using network analysis | 1.1 | 4 | Citations (PDF) |
| 70 | Comparison of Surgical Outcomes Between Invasive Mucinous and Non-Mucinous Lung Adenocarcinoma | 2.6 | 40 | Citations (PDF) |
| 71 | Full-coverage TP53 deep sequencing of recurrent head and neck squamous cell carcinoma facilitates prognostic assessment after recurrence | 1.4 | 10 | Citations (PDF) |
| 72 | Confirmation of NKX3-1 Expression in EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma Using Monoclonal Antibody Immunohistochemistry, RT-PCR, and RNA In Situ Hybridization | 2.3 | 17 | Citations (PDF) |
| 73 | Clinicopathologic Characterization of Epithelioid Hemangioendothelioma in a Series of 62 Cases | 2.3 | 39 | Citations (PDF) |
| 74 | NTRK fusion‐positive colorectal cancer in Japanese population | 0.8 | 13 | Citations (PDF) |
| 75 | RB1 gene mutations are a distinct predictive factor in Merkel cell carcinoma | 0.8 | 5 | Citations (PDF) |
| 76 | Real-World Evidence of Diagnostic Testing for Driver Oncogene Mutations in Lung Cancer in Japan | 0.6 | 5 | Citations (PDF) |
| 77 | The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC | 1.5 | 27 | Citations (PDF) |
| 78 | Alectinib for Miliary Lung Metastasis in ALK-Positive Lung Adenocarcinoma | 1.5 | 2 | Citations (PDF) |
| 79 | Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non–small-cell Lung Cancer: SQUAT trial (WJOG 12119L) | 2.1 | 24 | Citations (PDF) |
| 80 | Analysis of factors affecting the diagnostic yield of image-guided percutaneous core needle biopsy for peritoneal/omental lesions | 1.2 | 10 | Citations (PDF) |
| 81 | Characterization of the large‐scale Japanese patient‐derived xenograft (J‐PDX) library | 2.9 | 27 | Citations (PDF) |
| 82 | Tumor size in patients with severe pulmonary emphysema might be underestimated on preoperative CT | 3.0 | 4 | Citations (PDF) |
| 83 | Neoadjuvant Osimertinib With/Without Chemotherapy Versus Chemotherapy Alone for
EGFR
-Mutated Resectable Non-Small-Cell Lung Cancer: NeoADAURA | 1.7 | 167 | Citations (PDF) |
| 84 | MYB mediates downregulation of the colorectal cancer metastasis suppressor heterogeneous nuclear ribonucleoprotein L‐like during epithelial‐mesenchymal transition | 2.9 | 4 | Citations (PDF) |
| 85 | MO9-1 Real-world data of multiple diagnostic biomarker testing for lung cancer patients in Japan | 8.0 | 0 | Citations (PDF) |
| 86 | Long-Term Prognosis of Patients With Resected Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung | 1.5 | 171 | Citations (PDF) |
| 87 | Identification of novel SSX1 fusions in synovial sarcoma | 3.8 | 42 | Citations (PDF) |
| 88 | Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions | 2.7 | 23 | Citations (PDF) |
| 89 | Molecular testing in stage I–III non-small cell lung cancer: Approaches and challenges | 1.8 | 43 | Citations (PDF) |
| 90 | APC mutations are common in adenomas but infrequent in adenocarcinomas of the non-ampullary duodenum | 3.0 | 14 | Citations (PDF) |
| 91 | Cutaneous Primary NUT Carcinoma With BRD3-NUTM1 Fusion | 2.3 | 27 | Citations (PDF) |
| 92 | Canadian ROS proto-oncogene 1 study (CROS) for multi-institutional implementation of ROS1 testing in non-small cell lung cancer | 1.8 | 23 | Citations (PDF) |
| 93 | Radiological imaging and pathological findings of small lung adenocarcinoma: a narrative review | 0.9 | 2 | Citations (PDF) |
| 94 | Positive Correlation Between the Number of Circulating Tumor Cells in the Pulmonary Vein and Tumor Spread Through Air Spaces in Resected Non-small Cell Lung Cancer | 0.8 | 6 | Citations (PDF) |
| 95 | Adenocarcinoma in situ and minimally invasive adenocarcinoma in lungs of smokers: image feature differences from those in lungs of non-smokers | 2.0 | 5 | Citations (PDF) |
| 96 | Cryobiopsy as a reliable technique for the preoperative identification of micropapillary/solid components in early-stage lung adenocarcinoma | 1.8 | 10 | Citations (PDF) |
| 97 | MicroSEC filters sequence errors for formalin-fixed and paraffin-embedded samples | 3.1 | 10 | Citations (PDF) |
| 98 | PD-L1 immunohistochemistry comparison of 22C3 and 28-8 assays for gastric cancer | 0.9 | 33 | Citations (PDF) |
| 99 | Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women | 2.0 | 21 | Citations (PDF) |
| 100 | PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee | 1.5 | 296 | Citations (PDF) |
| 101 | The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non–Small Cell Lung Cancer | 1.5 | 151 | Citations (PDF) |
| 102 | Reassessing the SCLC Subtypes | 1.5 | 12 | Citations (PDF) |
| 103 | Lung cancer biomarker tests: the history and perspective in Japan | 1.3 | 7 | Citations (PDF) |
| 104 | The Isoform Matters in NUT Carcinoma: A Diagnostic Pitfall of p40 Immunohistochemistry | 1.5 | 28 | Citations (PDF) |
| 105 | Multiplex gene‐panel testing for lung cancer patients | 0.8 | 55 | Citations (PDF) |
| 106 | Clinicopathologic and Molecular Characteristics of Familial Adenomatous Polyposis–associated Traditional Serrated Adenoma | 2.3 | 6 | Citations (PDF) |
| 107 | O6-methylguanine DNA methyltransferase and glucose transporter 2 in foregut and hindgut gastrointestinal neuroendocrine neoplasms | 2.1 | 6 | Citations (PDF) |
| 108 | Tumor Location Is Associated With the Prevalence of Braf And Pik3ca Mutations in Patients with Wild-Type Ras Colorectal Cancer: A Prospective Multi-Center Cohort Study in Japan | 2.8 | 10 | Citations (PDF) |
| 109 | The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee | 1.5 | 266 | Citations (PDF) |
| 110 | Circulating Antibodies against Epstein–Barr Virus (EBV) and p53 in EBV-Positive and -Negative Gastric Cancer | 0.6 | 11 | Citations (PDF) |
| 111 | A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee | 1.5 | 512 | Citations (PDF) |
| 112 | Distal‐type bronchiolar adenoma of the lung expressing p16INK4a – morphologic, immunohistochemical, ultrastructural and genomic analysis – report of a case and review of the literature | 0.8 | 15 | Citations (PDF) |
| 113 | IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy | 1.5 | 431 | Citations (PDF) |
| 114 | Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck | 2.1 | 28 | Citations (PDF) |
| 115 | Negative reactions of BRAF mutation‐specific immunohistochemistry to non‐V600E mutations of BRAF | 0.8 | 14 | Citations (PDF) |
| 116 | Image-guided core needle biopsy in the diagnosis of malignant lymphoma: comparison with surgical excision biopsy | 2.1 | 23 | Citations (PDF) |
| 117 | Attempting to define sentinel node micrometastasis in oral squamous cell carcinoma | 1.0 | 6 | Citations (PDF) |
| 118 | Long‑term complete response in a patient with postoperative recurrent ALK‑rearranged lung adenocarcinoma treated with crizotinib: A case report | 0.9 | 4 | Citations (PDF) |
| 119 | Successful salvage surgery following multimodal therapy in a patient who harboured ALK‐rearranged advanced lung adenocarcinoma with multiple organ metastases | 0.5 | 6 | Citations (PDF) |
| 120 | Molecular alterations and PD-L1 expression in non-ampullary duodenal adenocarcinoma: Associations among clinicopathological, immunophenotypic and molecular features | 2.7 | 12 | Citations (PDF) |
| 121 | Dynamics of Circulating Tumor Cells Early After Targeting Therapy to Human EGFR-mutated Lung Cancers and HER2 Gene-amplified Gastric Cancers in Mice | 0.8 | 5 | Citations (PDF) |
| 122 | Prediction of pathological margin status using preoperative contrast-enhanced MRI in patients with early breast cancer who underwent skin-sparing mastectomy | 0.9 | 7 | Citations (PDF) |
| 123 | Helicobacter pylori (HP) infection alone, but not HP-induced atrophic gastritis, increases the risk of gastric lymphoma: a case-control study in Japan | 1.0 | 18 | Citations (PDF) |
| 124 | Long-term outcomes of metachronous neoplasms in the ileal pouch and rectum after surgical treatment in patients with familial adenomatous polyposis | 1.3 | 19 | Citations (PDF) |
| 125 | Important cytological findings for distinction between follicular variant and conventional papillary thyroid carcinoma, including noninvasive follicular thyroid tumors with papillary-like nuclear features | 1.0 | 12 | Citations (PDF) |
| 126 | Immunocytochemistry for predictive biomarker testing in lung cancer cytology | 1.3 | 109 | Citations (PDF) |
| 127 | Genomic landscape of allelic imbalance in premalignant atypical adenomatous hyperplasias of the lung | 6.6 | 21 | Citations (PDF) |
| 128 | Surgery for Pancreatic Neuroendocrine Tumor G3 and Carcinoma G3 Should be Considered Separately | 1.7 | 48 | Citations (PDF) |
| 129 | Usefulness of septal thickness measurement on endoscopic ultrasound as a predictor of malignancy of branched‐duct and mixed‐type intraductal papillary mucinous neoplasm of the pancreas | 2.7 | 22 | Citations (PDF) |
| 130 | Anaplastic lymphoma kinase expression in small‐cell lung cancer | 2.6 | 14 | Citations (PDF) |
| 131 | The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with
BRAF
V600E mutation | 2.1 | 13 | Citations (PDF) |
| 132 | The overall survival of breast cancer patients without adjuvant therapy | 1.0 | 2 | Citations (PDF) |
| 133 | Detection of circulating tumor cells in drainage venous blood from colorectal cancer patients using a new filtration and cytology-based automated platform | 1.5 | 28 | Citations (PDF) |
| 134 | Salvage surgery for small cell lung cancer after chemoradiotherapy | 1.3 | 15 | Citations (PDF) |
| 135 | A case of intrapulmonary solitary fibrous tumor harboring NAB2-STAT6 fusion gene | 0.0 | 0 | Citations (PDF) |
| 136 | Biopsy of palliative lesions following radiotherapy | 0.7 | 0 | Citations (PDF) |
| 137 | Circulating tumor cells detection in tumor draining vein of breast cancer patients | 2.7 | 26 | Citations (PDF) |
| 138 | Minimal residual disease after radical surgery in EGFR-mutant non-small cell lung cancer | 1.3 | 2 | Citations (PDF) |
| 139 | Simultaneous resections of left lung cancer and esophageal schwannoma using video‐assisted thoracoscopic surgery: A case report | 0.6 | 6 | Citations (PDF) |
| 140 | Clinicopathologic Features of Thymoma With the Expression of Programmed Death Ligand 1 | 2.6 | 24 | Citations (PDF) |
| 141 | Anaplastic variant of diffuse large B‐cell lymphoma with hallmark cell appearance: Two cases highlighting a broad diversity in the diagnostics | 0.8 | 8 | Citations (PDF) |
| 142 | Eighth Edition Staging of Thoracic Malignancies: Implications for the Reporting Pathologist | 1.7 | 27 | Citations (PDF) |
| 143 | The eighth TNM classification system for lung cancer: A consideration based on the degree of pleural invasion and involved neighboring structures | 1.8 | 24 | Citations (PDF) |
| 144 | A Real-Time Near-Infrared Fluorescence Imaging Method for the Detection of Oral Cancers in Mice Using an Indocyanine Green–Labeled Podoplanin Antibody | 1.5 | 25 | Citations (PDF) |
| 145 | Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology | 1.7 | 788 | Citations (PDF) |
| 146 | Validation of the digital PCR system in tyrosine kinase inhibitor‐resistant EGFR mutant non‐small‐cell lung cancer | 0.8 | 6 | Citations (PDF) |
| 147 | Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung | 1.5 | 48 | Citations (PDF) |
| 148 | HNRNPLL, a newly identified colorectal cancer metastasis suppressor, modulates alternative splicing of CD44 during epithelial-mesenchymal transition | 10.3 | 70 | Citations (PDF) |
| 149 | Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society | 1.7 | 75 | Citations (PDF) |
| 150 | Heterogeneous impact of smoking on major salivary gland cancer according to histopathological subtype: A case‐control study | 2.7 | 27 | Citations (PDF) |
| 151 | Immunophenotypic analysis of adult patients with T-cell lymphoblastic lymphoma treated with hyper-CVAD | 1.0 | 0 | Citations (PDF) |
| 152 | Inherited lung cancer syndromes targeting never smokers | 1.3 | 49 | Citations (PDF) |
| 153 | Establishment and validation of prognostic nomograms in first-line metastatic gastric cancer patients | 0.9 | 35 | Citations (PDF) |
| 154 | Targeting minimal residual disease after surgery with molecular targeted therapy: the real path to a cure? | 0.9 | 4 | Citations (PDF) |
| 155 | Current outcomes of postrecurrence survival in patients after resection of non-small cell lung cancer | 0.9 | 15 | Citations (PDF) |
| 156 | Evaluation of lobar lymph node metastasis in non-small cell lung carcinoma using modified total lesion glycolysis | 0.9 | 6 | Citations (PDF) |
| 157 | Detection of abundant megakaryocytes in pulmonary artery blood in lung cancer patients using a microfluidic platform | 1.8 | 22 | Citations (PDF) |
| 158 | Pre-existing pulmonary fibrosis is a risk factor for anti-PD-1-related pneumonitis in patients with non-small cell lung cancer: A retrospective analysis | 1.8 | 150 | Citations (PDF) |
| 159 | Spontaneous regression of lung squamous cell carcinoma with synchronous mediastinal progression: A case report | 1.5 | 8 | Citations (PDF) |
| 160 | Contribution of smoking habit to the prognosis of stage I KRAS-mutated non-small cell lung cancer | 0.7 | 4 | Citations (PDF) |
| 161 | Efficacy and Safety Data of Osimertinib in Elderly Patients with NSCLC Who Harbor the EGFR T790M Mutation After Failure of Initial EGFR-TKI Treatment | 0.8 | 27 | Citations (PDF) |
| 162 | Site-specific Chemotherapy Based on Predicted Primary Site by Pathological Profile for Carcinoma of Unknown Primary Site | 1.0 | 14 | Citations (PDF) |
| 163 | PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project | 1.5 | 732 | Citations (PDF) |
| 164 | Occult breast cancer may originate from ectopic breast tissue present in axillary lymph nodes | 1.8 | 41 | Citations (PDF) |
| 165 | A Rare Case of Ampullary Goblet Cell Carcinoid | 0.5 | 6 | Citations (PDF) |
| 166 | A case of second primary lung cancer diagnosed by surgical resection at salvage setting | 0.3 | 0 | Citations (PDF) |
| 167 | Sinonasal squamous cell carcinoma and EGFR mutations: a molecular footprint of a benign lesion | 2.6 | 44 | Citations (PDF) |
| 168 | HNRNPLL stabilizes mRNA for DNA replication proteins and promotes cell cycle progression in colorectal cancer cells | 2.9 | 17 | Citations (PDF) |
| 169 | Fibrolamellar Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Multidisciplinary Therapy | 0.5 | 7 | Citations (PDF) |
| 170 | Increased Synthesis of MCL-1 Protein Underlies Initial Survival of
EGFR
-Mutant Lung Cancer to EGFR Inhibitors and Provides a Novel Drug Target | 4.5 | 62 | Citations (PDF) |
| 171 | Epithelioid hemangioendothelioma of the parotid gland: a case report | 0.3 | 6 | Citations (PDF) |
| 172 | Clinical and in vitro studies of the correlation between MGMT and the effect of streptozocin in pancreatic NET | 1.3 | 16 | Citations (PDF) |
| 173 | Association between GWAS-identified lung adenocarcinoma susceptibility loci andEGFRmutations in never-smoking Asian women, and comparison with findings from Western populations | 2.1 | 57 | Citations (PDF) |
| 174 | Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma | 2.7 | 65 | Citations (PDF) |
| 175 | Expression of cancer/testis antigens in salivary gland carcinomas with reference to MAGE‐A and NY‐ESO‐1 expression in adenoid cystic carcinoma | 2.6 | 13 | Citations (PDF) |
| 176 | Clinical outcomes of platinum-based chemotherapy according to T790M mutation status in EGFR-positive non-small cell lung cancer patients after initial EGFR-TKI failure | 1.8 | 20 | Citations (PDF) |
| 177 | Association Between EGFR T790M Status and Progression Patterns During Initial EGFR-TKI Treatment in Patients Harboring EGFR Mutation | 2.1 | 35 | Citations (PDF) |
| 178 | Rb Loss and
KRAS
Mutation Are Predictors of the Response to Platinum-Based Chemotherapy in Pancreatic Neuroendocrine Neoplasm with Grade 3: A Japanese Multicenter Pancreatic NEN-G3 Study | 4.5 | 188 | Citations (PDF) |
| 179 | Diagnosis of Acute Cellular Rejection and Antibody-Mediated Rejection on Lung Transplant Biopsies: A Perspective From Members of the Pulmonary Pathology Society | 1.7 | 70 | Citations (PDF) |
| 180 | Uptake of 123I-metaiodobenzylguanidine by gastrointestinal stromal tumor | 0.5 | 6 | Citations (PDF) |
| 181 | MYB,MYBL1,MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma | 2.6 | 74 | Citations (PDF) |
| 182 | Scientific Advances in Thoracic Oncology 2016 | 1.5 | 50 | Citations (PDF) |
| 183 | The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases | 1.5 | 134 | Citations (PDF) |
| 184 | Comparative evaluation of new and conventional classifications of magnifying endoscopy with narrow band imaging for invasion depth of superficial esophageal squamous cell carcinoma | 0.6 | 10 | Citations (PDF) |
| 185 | Genomic Landscape of Atypical Adenomatous Hyperplasia Reveals Divergent Modes to Lung Adenocarcinoma | 2.6 | 129 | Citations (PDF) |
| 186 | Depth of response predicts the clinical outcome of advanced HER2-positive gastric cancer to trastuzumab-based first-line chemotherapy | 1.3 | 15 | Citations (PDF) |
| 187 | Reply to Letter “The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases.” | 1.5 | 5 | Citations (PDF) |
| 188 | Correlation between human epidermal growth factor receptor 2 expression level and efficacy of trastuzumab beyond progression in metastatic gastric cancer | 1.1 | 9 | Citations (PDF) |
| 189 | Histological type predicts mediastinal metastasis and surgical outcome in resected cN1 non-small cell lung cancer | 0.9 | 8 | Citations (PDF) |
| 190 | Sentinel node biopsy for oral cancer: A prospective multicenter Phase II trial | 1.1 | 50 | Citations (PDF) |
| 191 | Slow-growing amelanotic malignant melanoma of the esophagus with long survival: a case report and review of the literature | 1.3 | 3 | Citations (PDF) |
| 192 | The Features of Colorectal Tumors in a Patient with Li-Fraumeni Syndrome | 0.5 | 5 | Citations (PDF) |
| 193 | Current outcomes of postrecurrence survival in patients after resection of non-small cell lung cancer | 8.0 | 0 | Citations (PDF) |
| 194 | Not like breast cancer, but like breast cancer: micrometastasis and micropapillary structure in lung cancer | 0.9 | 1 | Citations (PDF) |
| 195 | Acute phase dynamics of circulating tumor cells after paclitaxel and doxorubicin chemotherapy in breast cancer mouse models | 1.8 | 18 | Citations (PDF) |
| 196 | Pathologic Diagnosis and Genetic Analysis of a Lung Tumor Needle Biopsy Specimen Obtained Immediately After Radiofrequency Ablation | 1.3 | 19 | Citations (PDF) |
| 197 | Clinical Efficacy of Alectinib in Patients with ALK-Rearranged Non-small Cell Lung Cancer After Ceritinib Failure | 0.8 | 7 | Citations (PDF) |
| 198 | Therapeutic value of lymph node dissection for right middle lobe non-small-cell lung cancer | 0.9 | 8 | Citations (PDF) |
| 199 | Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Naïve Patients with Advanced Lung Adenocarcinoma | 1.5 | 38 | Citations (PDF) |
| 200 | Microglandular adenosis associated with triple‐negative breast cancer is a neoplastic lesion of triple‐negative phenotype harbouring TP53 somatic mutations | 3.2 | 65 | Citations (PDF) |
| 201 | Rapid and dramatic response to alectinib in an anaplastic lymphoma kinase rearranged non-small-cell lung cancer patient who is critically ill | 0.8 | 18 | Citations (PDF) |
| 202 | Anti‐Helicobacter pylori Antibody Profiles in Epstein‐Barr virus (EBV)‐Positive and EBV‐Negative Gastric Cancer | 2.2 | 42 | Citations (PDF) |
| 203 | The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation–Positive Non–Small Cell Lung Cancer: Status in 2016 | 1.5 | 185 | Citations (PDF) |
| 204 | Prediction of high risk for death in patients with follicular lymphoma receiving rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in first-line chemotherapy | 1.0 | 12 | Citations (PDF) |
| 205 | Biomarker Testing in Lung Carcinoma Cytology Specimens: A Perspective From Members of the Pulmonary Pathology Society | 1.7 | 107 | Citations (PDF) |
| 206 | Programmed Death Ligand-1 Immunohistochemistry— A New Challenge for Pathologists: A Perspective From Members of the Pulmonary Pathology Society | 1.7 | 108 | Citations (PDF) |
| 207 | Clinical impact of crizotinib on central nervous system progression in ALK-positive non-small lung cancer | 1.8 | 47 | Citations (PDF) |
| 208 | Impact of intraoperative specimen mammography on margins in breast-conserving surgery | 0.9 | 23 | Citations (PDF) |
| 209 | miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer | 1.5 | 0 | Citations (PDF) |
| 210 | Standardized uptake value on 18 F-FDG-PET/CT is a predictor of EGFR T790M mutation status in patients with acquired resistance to EGFR-TKIs | 1.8 | 22 | Citations (PDF) |
| 211 | The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung Cancer | 1.5 | 247 | Citations (PDF) |
| 212 | Prognostic Value of Drinking Status and Aldehyde Dehydrogenase 2 Polymorphism in Patients With Head and Neck Squamous Cell Carcinoma | 0.2 | 19 | Citations (PDF) |
| 213 | Transbronchial Lung Cryobiopsy for Interstitial Lung Disease Diagnosis: A Perspective From Members of the Pulmonary Pathology Society | 1.7 | 27 | Citations (PDF) |
| 214 | Impact of the oncogenic status on the mode of recurrence in resected non-small cell lung cancer | 1.3 | 10 | Citations (PDF) |
| 215 | Liquid Biopsy in Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society | 1.7 | 71 | Citations (PDF) |
| 216 | 12P Volatolomic signatures of anaplastic lymphoma kinase gene rearrangement in adenocarcinoma | 1.5 | 0 | Citations (PDF) |
| 217 | The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer | 1.5 | 669 | Citations (PDF) |
| 218 | “Pseudoprogression” of Pulmonary Pleomorphic Carcinoma during Nivolumab Therapy | 1.5 | 31 | Citations (PDF) |
| 219 | ITPKA Gene Body Methylation Regulates Gene Expression and Serves as an Early Diagnostic Marker in Lung and Other Cancers | 1.5 | 44 | Citations (PDF) |
| 220 | Estimation of the pathological invasive size of pulmonary adenocarcinoma using high-resolution computed tomography of the chest: A consideration based on lung and mediastinal window settings | 1.8 | 34 | Citations (PDF) |
| 221 | Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma | 2.1 | 105 | Citations (PDF) |
| 222 | A risk prediction model for colorectal cancer using genome-wide association study-identified polymorphisms and established risk factors among Japanese: results from two independent case–control studies | 1.3 | 23 | Citations (PDF) |
| 223 | Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers | 1.5 | 13 | Citations (PDF) |
| 224 | Transformation to SCLC after Treatment with the ALK Inhibitor Alectinib | 1.5 | 137 | Citations (PDF) |
| 225 | Diagnostic performance and factors influencing the accuracy of EUS-FNA of pancreatic neuroendocrine neoplasms | 3.0 | 62 | Citations (PDF) |
| 226 | Meta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian women | 2.1 | 60 | Citations (PDF) |
| 227 | A short interval between bevacizumab and anti-epithelial growth factor receptor therapy interferes with efficacy of subsequent anti-EGFR therapy for refractory colorectal cancer | 1.3 | 13 | Citations (PDF) |
| 228 | Plasma microRNA-103, microRNA-107, and microRNA-194 levels are not biomarkers for human diffuse gastric cancer | 1.8 | 11 | Citations (PDF) |
| 229 | Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art? | 1.5 | 259 | Citations (PDF) |
| 230 | Comparison of intratumoral heterogeneity of HER2 expression between primary tumor and multiple organ metastases in gastric cancer: Clinicopathological study of three autopsy cases and one resected case | 0.8 | 6 | Citations (PDF) |
| 231 | Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancer | 2.7 | 79 | Citations (PDF) |
| 232 | EGFR Mutation Impact on Definitive Concurrent Chemoradiation Therapy for Inoperable Stage III Adenocarcinoma | 1.5 | 71 | Citations (PDF) |
| 233 | Spatiotemporal T790M Heterogeneity in Individual Patients with EGFR-Mutant Non–Small-Cell Lung Cancer after Acquired Resistance to EGFR-TKI | 1.5 | 150 | Citations (PDF) |
| 234 | Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long‐term follow‐up study: proposals for follow‐up strategies | 1.8 | 37 | Citations (PDF) |
| 235 | The 2015 World Health Organization Classification of Lung Tumors | 1.5 | 4,325 | Citations (PDF) |
| 236 | ROS1 Immunohistochemistry Among Major Genotypes of Non–Small-Cell Lung Cancer | 2.1 | 63 | Citations (PDF) |
| 237 | Clinical course of gastrointestinal stromal tumor diagnosed by endoscopic ultrasound‐guided fine‐needle aspiration | 2.7 | 43 | Citations (PDF) |
| 238 | Combining Onartuzumab with Erlotinib Inhibits Growth of Non–Small Cell Lung Cancer with Activating
EGFR
Mutations and HGF Overexpression | 1.2 | 28 | Citations (PDF) |
| 239 | EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIs | 4.5 | 191 | Citations (PDF) |
| 240 | Additional Midline Biopsies of the Peripheral Zone Associated with the First Endorectal Standard Sextant Pattern Improves the Accuracy of Prostate Cancer Detection in Japanese Patients | 0.8 | 3 | Citations (PDF) |
| 241 | Genetic features of pulmonary adenocarcinoma presenting with ground-glass nodules: the differences between nodules with and without growth | 8.0 | 138 | Citations (PDF) |
| 242 | Comprehensive genomic profiles of small cell lung cancer | 30.6 | 2,230 | Citations (PDF) |
| 243 | GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas | 1.9 | 83 | Citations (PDF) |
| 244 | Lack of Association between the BIM Deletion Polymorphism and the Risk of Lung Cancer with and without EGFR Mutations | 1.5 | 14 | Citations (PDF) |
| 245 | EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey | 1.5 | 180 | Citations (PDF) |
| 246 | miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer | 2.2 | 52 | Citations (PDF) |
| 247 | Increased T-cell responses to Epstein–Barr virus with high viral load in patients with Epstein–Barr virus-positive diffuse large B-cell lymphoma | 1.0 | 11 | Citations (PDF) |
| 248 | Minute perivascular epithelioid cell (PEC) nests in the abdominal lymph nodes—a putative precursor of PEComa | 0.8 | 7 | Citations (PDF) |
| 249 | Lymph Node Metastases and Prognosis in Left Upper Division Non-Small Cell Lung Cancers: The Impact of Interlobar Lymph Node Metastasis | 1.5 | 23 | Citations (PDF) |
| 250 | A Case of Recurrent Pulmonary Artery Intimal Sarcoma After Left Pneumonectomy | 0.1 | 0 | Citations (PDF) |
| 251 | A Case of Recurrent Thymic Atypical Carcinoid with Pleural and Peritoneal Dissemination Six Years After Thymectomy | 0.1 | 2 | Citations (PDF) |
| 252 | A Basis of Molecular Pathology for Clinicians | 0.1 | 0 | Citations (PDF) |
| 253 | Development of a New Rapid Isolation Device for Circulating Tumor Cells (CTCs) Using 3D Palladium Filter and Its Application for Genetic Analysis | 1.5 | 75 | Citations (PDF) |
| 254 | Improved survival of gastric cancer with tumour Epstein–Barr virus positivity: an international pooled analysis | 10.3 | 355 | Citations (PDF) |
| 255 | Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33 | 2.1 | 104 | Citations (PDF) |
| 256 | Combination of cyst fluid CEA and CA 125 is an accurate diagnostic tool for differentiating mucinous cystic neoplasms from intraductal papillary mucinous neoplasms | 0.8 | 32 | Citations (PDF) |
| 257 | Gene expression profiling of Epstein–Barr virus‐positive diffuse large B‐cell lymphoma of the elderly reveals alterations of characteristic oncogenetic pathways | 2.9 | 78 | Citations (PDF) |
| 258 | ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer | 3.2 | 126 | Citations (PDF) |
| 259 | An International Interpretation Study Using the ALK IHC Antibody D5F3 and a Sensitive Detection Kit Demonstrates High Concordance between ALK IHC and ALK FISH and between Evaluators | 1.5 | 159 | Citations (PDF) |
| 260 | Canadian Anaplastic Lymphoma Kinase Study: A Model for Multicenter Standardization and Optimization of ALK Testing in Lung Cancer | 1.5 | 76 | Citations (PDF) |
| 261 | Reproducibility of Histopathological Diagnosis in Poorly Differentiated NSCLC: An International Multiobserver Study | 1.5 | 41 | Citations (PDF) |
| 262 | Impact of intrinsic subtype on predicting axillary lymph node metastasis in breast cancer | 1.1 | 11 | Citations (PDF) |
| 263 | A novel technique for endoscopic transpapillary “mapping biopsy specimens” of superficial intraductal spread of bile duct carcinoma (with videos) | 1.0 | 30 | Citations (PDF) |
| 264 | Anaplastic lymphoma kinase gene rearrangements in patients with advanced‐stage non‐small‐cell lung cancer: CT characteristics and response to chemotherapy | 2.0 | 23 | Citations (PDF) |
| 265 | Case–case comparison of smoking and alcohol risk associations with Epstein–Barr virus‐positive gastric cancer | 2.8 | 56 | Citations (PDF) |
| 266 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation | 10.8 | 112 | Citations (PDF) |
| 267 | CD74–NRG1
Fusions in Lung Adenocarcinoma | 6.8 | 284 | Citations (PDF) |
| 268 | The association between baseline clinical–radiological characteristics and growth of pulmonary nodules with ground-glass opacity | 1.8 | 103 | Citations (PDF) |
| 269 | Lung adenocarcinoma subtypes definable by lung development-related miRNA expression profiles in association with clinicopathologic features | 2.2 | 44 | Citations (PDF) |
| 270 | CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutation | 1.8 | 13 | Citations (PDF) |
| 271 | Spatiotemporal T790M Heterogeneity in a Patient with EGFR-Mutant Non–Small-Cell Lung Cancer | 1.5 | 6 | Citations (PDF) |
| 272 | Deficient HER3 expression in poorly-differentiated colorectal cancer cells enhances gefitinib sensitivity | 3.6 | 13 | Citations (PDF) |
| 273 | Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas? | 3.0 | 63 | Citations (PDF) |
| 274 | Preferential HER2 expression in liver metastases and EGFR expression in peritoneal metastases in patients with advanced gastric cancer | 3.0 | 36 | Citations (PDF) |
| 275 | Immunohistochemical expression of myoepithelial markers in adenomyoepithelioma of the breast: a unique paradoxical staining pattern of high-molecular weight cytokeratins | 1.9 | 21 | Citations (PDF) |
| 276 | Salvage therapy with single agent L-asparaginase followed by local irradiation in an elderly patient with CD56-positve primary isolated extramedullary T-cell lymphoblastic lymphoma of the sinus | 1.0 | 1 | Citations (PDF) |
| 277 | CRIPTO1 expression in EGFR-mutant NSCLC elicits intrinsic EGFR-inhibitor resistance | 6.6 | 99 | Citations (PDF) |
| 278 | Combination of High Serum Lactate Dehydrogenase Levels at the Time of First Diagnosis and Progression Predicts Early Lymphoma Related Death in Patients with Follicular Lymphoma Receiving R-CHOP RegimenBlood, 2014, 124, 2972-2972 | 3.6 | 0 | Citations (PDF) |
| 279 | BCL10 as a useful marker for pancreatic acinar cell carcinoma, especially using endoscopic ultrasound cytology specimens | 0.8 | 73 | Citations (PDF) |
| 280 | Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind FOXA1 and E2F1 | 4.0 | 107 | Citations (PDF) |
| 281 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer | 14.1 | 524 | Citations (PDF) |
| 282 | Genome-wide association study of genetic factors related to confectionery intake: Potential roles of theADIPOQgene | 2.8 | 12 | Citations (PDF) |
| 283 | Prognostic and Predictive Implication of Epidermal Growth Factor Receptor Gene Mutation on Overall Survival in Non-Small Cell Lung Cancer Patients With Postsurgical Recurrence | 1.0 | 0 | Citations (PDF) |
| 284 | Solitary pulmonary metastasis from lung cancer harboring EML4–ALK after a 15-year disease-free interval | 1.8 | 9 | Citations (PDF) |
| 285 | EGFR mutation analysis in sputum of lung cancer patients: A multitechnique study | 1.8 | 35 | Citations (PDF) |
| 286 | Behavior of Bone Marrow–Derived Cells Following in Vivo Transplantation | 2.8 | 0 | Citations (PDF) |
| 287 | Surgery for NSCLC in the era of personalized medicine | 54.3 | 92 | Citations (PDF) |
| 288 | Genome-wide association studies identify four ER negative–specific breast cancer risk loci | 14.1 | 403 | Citations (PDF) |
| 289 | Time to first cigarette and lung cancer risk in Japan | 8.0 | 13 | Citations (PDF) |
| 290 | Transformation to Sarcomatoid Carcinoma in ALK-Rearranged Adenocarcinoma, Which Developed Acquired Resistance to Crizotinib and Received Subsequent Chemotherapies | 1.5 | 39 | Citations (PDF) |
| 291 | Diagnosis of Lung Cancer in Small Biopsies and Cytology: Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification | 1.7 | 395 | Citations (PDF) |
| 292 | Evaluation of Ki-67 index in EUS–FNA specimens for the assessment of malignancy risk in pancreatic neuroendocrine tumors | 0.3 | 138 | Citations (PDF) |
| 293 | The aldehyde dehydrogenase 2 (ALDH2) Glu504Lys polymorphism interacts with alcohol drinking in the risk of stomach cancer | 2.2 | 78 | Citations (PDF) |
| 294 | How Long Should Small Lung Lesions of Ground-Glass Opacity be Followed? | 1.5 | 113 | Citations (PDF) |
| 295 | HNF4α as a Marker for Invasive Mucinous Adenocarcinoma of the Lung | 2.3 | 98 | Citations (PDF) |
| 296 | Interobserver Agreement in the Nuclear Grading of Primary Pulmonary Adenocarcinoma | 1.5 | 31 | Citations (PDF) |
| 297 | Met Is the Most Frequently Amplified Gene in Endometriosis-Associated Ovarian Clear Cell Adenocarcinoma and Correlates with Worsened Prognosis | 1.5 | 76 | Citations (PDF) |
| 298 | Impact of PSCA Variation on Gastric Ulcer Susceptibility | 1.5 | 16 | Citations (PDF) |
| 299 | Cytoplasmic expression of LGR5 in pancreatic adenocarcinoma | 2.2 | 16 | Citations (PDF) |
| 300 | Risk of second malignancies in patients with gastric marginal zone lymphomas of mucosa associate lymphoid tissue (MALT) | 3.0 | 17 | Citations (PDF) |
| 301 | Cigarette Smoking and Pancreatic Cancer Risk: A Revisit with an Assessment of the Nicotine Dependence Phenotype | 0.9 | 7 | Citations (PDF) |
| 302 | Prognostic Value Of GELF Criteria and FLIPI2 For Newly Diagnosed Follicular Lymphoma Receiving R-CHOP ChemotherapyBlood, 2013, 122, 4368-4368 | 3.6 | 0 | Citations (PDF) |
| 303 | First report of a mucosa-associated lymphoid tissue (MALT) lymphoma of the esophagus diagnosed by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) | 0.3 | 9 | Citations (PDF) |
| 304 | Concurrent Gastric MALT and Hodgkin Lymphoma | 0.6 | 16 | Citations (PDF) |
| 305 | Association between a Genome-Wide Association Study-Identified Locus and the Risk of Lung Cancer in Japanese Population | 1.5 | 38 | Citations (PDF) |
| 306 | P90 RSK arranges Chk1 in the nucleus for monitoring of genomic integrity during cell proliferation | 1.8 | 55 | Citations (PDF) |
| 307 | Folate, alcohol, and aldehyde dehydrogenase 2 polymorphism and the risk of oral and pharyngeal cancer in Japanese | 1.3 | 33 | Citations (PDF) |
| 308 | G-CSF-Producing Malignant Pleural Mesothelioma | 0.6 | 3 | Citations (PDF) |
| 309 | Association between dietary folate intake and clinical outcome in head and neck squamous cell carcinoma | 8.0 | 26 | Citations (PDF) |
| 310 | TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth | 5.9 | 220 | Citations (PDF) |
| 311 | Highly Sensitive Detection of EGFR T790M Mutation Using Colony Hybridization Predicts Favorable Prognosis of Patients with Lung Cancer Harboring Activating EGFR Mutation | 1.5 | 112 | Citations (PDF) |
| 312 | Pulmonary Cysts of Birt-Hogg-Dubé Syndrome | 2.3 | 102 | Citations (PDF) |
| 313 | Selected Polymorphisms of Base Excision Repair Genes and Pancreatic Cancer Risk in Japanese | 0.2 | 44 | Citations (PDF) |
| 314 | Impact of age on epidermal growth factor receptor mutation in lung cancer | 1.8 | 36 | Citations (PDF) |
| 315 | Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study | 3.8 | 234 | Citations (PDF) |
| 316 | Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene | 1.8 | 109 | Citations (PDF) |
| 317 | Diagnostic yield of endoscopic retrograde cholangiography and of EUS‐guided fine needle aspiration sampling in gallbladder carcinomas | 1.8 | 49 | Citations (PDF) |
| 318 | Intraoperative Molecular Assessment for Lymph Node Metastasis in Head and Neck Squamous Cell Carcinoma Using One-Step Nucleic Acid Amplification (OSNA) Assay | 1.7 | 30 | Citations (PDF) |
| 319 | A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer | 22.6 | 550 | Citations (PDF) |
| 320 | Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses | 1.0 | 86 | Citations (PDF) |
| 321 | Conversion from the “oncogene addiction” to “drug addiction” by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation | 1.8 | 58 | Citations (PDF) |
| 322 | Differential impact of body mass index and its change on the risk of breast cancer by molecular subtype: A case-control study in Japanese women | 1.4 | 12 | Citations (PDF) |
| 323 | A Screening Method for the ALK Fusion Gene in NSCLC | 1.7 | 76 | Citations (PDF) |
| 324 | Histone H1 expression in human prostate cancer tissues and cell lines | 0.8 | 21 | Citations (PDF) |
| 325 | RET finger protein expression is associated with prognosis in lung cancer with epidermal growth factor receptor mutations | 0.8 | 26 | Citations (PDF) |
| 326 | Diagnostic ability and factors affecting accuracy of endoscopic ultrasound-guided fine needle aspiration for pancreatic solid lesions: Japanese large single center experience | 3.0 | 163 | Citations (PDF) |
| 327 | Prognostic value of K-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer | 3.0 | 107 | Citations (PDF) |
| 328 | Akt kinase-interacting protein1, a novel therapeutic target for lung cancer with EGFR-activating and gatekeeper mutations | 5.2 | 25 | Citations (PDF) |
| 329 | Prognosis of patients with advanced gastric cancer by HER2 status and trastuzumab treatment | 3.0 | 91 | Citations (PDF) |
| 330 | Durable Local Disease Control and Survival in Patients with Limited-Stage Diffuse Large B-Cell Lymphoma Receiving Involved-Node Radiation Therapy Plus Short-Course R-CHOP or CHOP Chemotherapy: Involved-Node Versus Involved-Field Radiation TherapyBlood, 2012, 120, 3665-3665 | 3.6 | 1 | Citations (PDF) |
| 331 | Lung Adenocarcinoma Coexistent with Pulmonary Non-tuberculous Mycobacteriosis | 0.1 | 2 | Citations (PDF) |
| 332 | Role of Endoscopic Ultrasound and Endoscopic Ultrasound-Guided Fine-Needle Aspiration in Diagnosing Metastasis to the Pancreas: A Tertiary Center Experience | 0.8 | 35 | Citations (PDF) |
| 333 | Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers | 1.8 | 152 | Citations (PDF) |
| 334 | Do all lung adenocarcinomas follow a stepwise progression? | 1.8 | 131 | Citations (PDF) |
| 335 | Current Concept of Endoscopic Ultrasound-Guided Fine Needle Aspiration for Pancreatic Cancer | 0.8 | 34 | Citations (PDF) |
| 336 | Clinical Impact of KRAS Gene Mutation Analysis, in EUS-FNA Specimens From Pancreatic Mass Lesions | 0.9 | 0 | Citations (PDF) |
| 337 | miR-375
Is Activated by ASH1 and Inhibits YAP1 in a Lineage-Dependent Manner in Lung Cancer | 2.6 | 138 | Citations (PDF) |
| 338 | Epithelial to Mesenchymal Transition in an Epidermal Growth Factor Receptor-Mutant Lung Cancer Cell Line with Acquired Resistance to Erlotinib | 1.5 | 256 | Citations (PDF) |
| 339 | Pathological complete response of colorectal liver metastases following chemotherapy with S-1 and oxaliplatin (SOX) in combination with bevacizumab: A case report | 1.1 | 1 | Citations (PDF) |
| 340 | ABO blood group alleles and the risk of pancreatic cancer in a Japanese population | 2.9 | 71 | Citations (PDF) |
| 341 | Association between insulin‐like growth factor‐1 polymorphisms and stomach cancer risk in a Japanese population | 2.9 | 21 | Citations (PDF) |
| 342 | BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer | 4.1 | 381 | Citations (PDF) |
| 343 | Epstein–Barr virus‐associated lymphoproliferative disorder presenting with classical Hodgkin lymphoma and developing as peripheral T‐cell lymphoma 9 years later: A case report of composite lymphoma | 0.8 | 10 | Citations (PDF) |
| 344 | Lung cancers unrelated to smoking: characterized by single oncogene addiction? | 1.6 | 24 | Citations (PDF) |
| 345 | Proteasomal non‐catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas | 2.1 | 56 | Citations (PDF) |
| 346 | Inverse association between toothbrushing and upper aerodigestive tract cancer risk in a Japanese population | 1.4 | 55 | Citations (PDF) |
| 347 | ABO
Genotype and the Risk of Gastric Cancer, Atrophic Gastritis, and
Helicobacter pylori
Infection | 0.6 | 80 | Citations (PDF) |
| 348 | Hepatocyte Growth Factor Expression in EGFR Mutant Lung Cancer with Intrinsic and Acquired Resistance to Tyrosine Kinase Inhibitors in a Japanese Cohort | 1.5 | 208 | Citations (PDF) |
| 349 | Dramatic Tumor Response to Everolimus for Malignant Epithelioid Angiomyolipoma | 1.3 | 45 | Citations (PDF) |
| 350 | International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma | 1.5 | 4,669 | Citations (PDF) |
| 351 | Role and Relevance of TrkB Mutations and Expression in Non–Small Cell Lung Cancer | 4.5 | 57 | Citations (PDF) |
| 352 | Nodal Relapse After Helicobacter pylori Eradication in a Patient With Primary Localized Gastric Mucosa-Associated Lymphoid Tissue Lymphoma | 0.7 | 3 | Citations (PDF) |
| 353 | Lapatinib Plus Trastuzumab for a Patient with Heavily Pre-treated Gastric Cancer that Progressed after Trastuzumab | 1.3 | 7 | Citations (PDF) |
| 354 | Long-term medroxyprogesterone acetate therapy for low-grade endometrial stromal sarcoma | 1.6 | 31 | Citations (PDF) |
| 355 | High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancers | 1.6 | 21 | Citations (PDF) |
| 356 | Patterns of recurrence and outcome in patients with surgically resected small cell lung cancer | 1.6 | 27 | Citations (PDF) |
| 357 | A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population | 1.8 | 90 | Citations (PDF) |
| 358 | HLA-A Alleles and the Risk of Cervical Squamous Cell Carcinoma in Japanese Women | 0.2 | 20 | Citations (PDF) |
| 359 | Pre-operative diagnosis of synchronous solid-pseudopapillary neoplasms of the pancreas | 0.5 | 5 | Citations (PDF) |
| 360 | EGFR mutations and the terminal respiratory unit | 6.8 | 115 | Citations (PDF) |
| 361 | Effect of gefitinib on the survival of patients with recurrence of lung adenocarcinoma after surgery: A retrospective case-matching cohort study | 1.0 | 11 | Citations (PDF) |
| 362 | Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasound‐guided fine needle aspiration | 0.8 | 44 | Citations (PDF) |
| 363 | Coexistence of primary pulmonary Hodgkin lymphoma and gastric MALT lymphoma associated with Epstein-Barr virus infection: A case report | 0.8 | 15 | Citations (PDF) |
| 364 | Phase II study of preoperative systemic treatment with the combination of docetaxel and trastuzumab in patients with locally advanced HER-2-overexpressing breast cancer | 0.9 | 4 | Citations (PDF) |
| 365 | Characteristic methylation profile in CpG island methylator phenotype‐negative distal colorectal cancers | 2.8 | 35 | Citations (PDF) |
| 366 | Angioimmunoblastic T-cell lymphoma with autoimmune thrombocytopenia: A report of two cases | 2.2 | 8 | Citations (PDF) |
| 367 | Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer | 3.3 | 529 | Citations (PDF) |
| 368 | Comparison between self‐reported facial flushing after alcohol consumption and ALDH2 Glu504Lys polymorphism for risk of upper aerodigestive tract cancer in a Japanese population | 2.9 | 71 | Citations (PDF) |
| 369 | Morphological Features of the Most Advanced Intra-Tumor Component in Multistep Progression | 0.2 | 0 | Citations (PDF) |
| 370 | Immunohistochemical Detection of EGFR Mutation Using Mutation-Specific Antibodies in Lung Cancer | 4.5 | 113 | Citations (PDF) |
| 371 | Regulation of DNA Polymerase POLD4 Influences Genomic Instability in Lung Cancer | 2.6 | 47 | Citations (PDF) |
| 372 | Phase II Study of Combination Chemotherapy with Biweekly Cetuximab and Irinotecan for Pre-treated Metastatic Colorectal Cancer Harboring Wild-type KRAS | 1.3 | 3 | Citations (PDF) |
| 373 | Novel Metastasis-Related Gene CIM Functions in the Regulation of Multiple Cellular Stress–Response Pathways | 2.6 | 24 | Citations (PDF) |
| 374 | Reciprocal and Complementary Role of
MET
Amplification and
EGFR
T790M Mutation in Acquired Resistance to Kinase Inhibitors in Lung Cancer | 4.5 | 205 | Citations (PDF) |
| 375 | Folate Intake along with Genetic Polymorphisms in Methylenetetrahydrofolate Reductase and Thymidylate Synthase in Patients with Advanced Gastric Cancer | 0.6 | 36 | Citations (PDF) |
| 376 | Analysis of Genetic Variants in Never-Smokers with Lung Cancer Facilitated by an Internet-Based Blood Collection Protocol: A Preliminary Report | 4.5 | 87 | Citations (PDF) |
| 377 | Impact of smoking on lung cancer risk is stronger in those with the homozygous aldehyde dehydrogenase 2 null allele in a Japanese population | 2.2 | 40 | Citations (PDF) |
| 378 | Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis of retroperitoneal schwannoma | 0.3 | 7 | Citations (PDF) |
| 379 | Endoscopic features of short-term progression of esophageal intramural pseudodiverticulosis | 0.3 | 12 | Citations (PDF) |
| 380 | Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms | 0.3 | 123 | Citations (PDF) |
| 381 | Diagnostic utility of EUS-guided FNA in patients with gastric submucosal tumors | 1.0 | 230 | Citations (PDF) |
| 382 | M1441: Clinical Effectiveness of Endoscopic Ultrasound-Guided Fine-Needle Aspiration (EUS-FNA) for Diagnosis of Pancreatic Neuroendocrine Tumors (PNETs) | 1.0 | 0 | Citations (PDF) |
| 383 | Cycleave polymerase chain reaction method is practically applicable for V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)/V-raf murine sarcoma viral oncogene homolog B1 (BRAF) genotyping in colorectal cancer | 2.9 | 27 | Citations (PDF) |
| 384 | Corticosteroids Correct Aberrant CFTR Localization in the Duct and Regenerate Acinar Cells in Autoimmune Pancreatitis | 0.9 | 105 | Citations (PDF) |
| 385 | Absence of the Caveolin-1 P132L Mutation in Cancers of the Breast and Other Organs | 1.9 | 16 | Citations (PDF) |
| 386 | Thyroid transcription factor 1 expression in ovarian carcinomas is an independent prognostic factor | 1.7 | 29 | Citations (PDF) |
| 387 | Aberrant expression of interferon regulatory factor 3 in human lung cancer | 1.5 | 15 | Citations (PDF) |
| 388 | Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial | 16.1 | 4,026 | Citations (PDF) |
| 389 | EGFR mutations in non-small-cell lung cancer – Authors' reply | 16.1 | 1 | Citations (PDF) |
| 390 | EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors | 26.4 | 1,179 | Citations (PDF) |
| 391 | Phase II study of combination chemotherapy with irinotecan and cetuximab for pretreated metastatic colorectal cancer harboring wild-type KRAS | 1.6 | 13 | Citations (PDF) |
| 392 | Follow-up after intraoperative sentinel node biopsy of N0 neck oral cancer patients | 1.1 | 39 | Citations (PDF) |
| 393 | Clinical benefit of endocrine therapy for benign metastasizing leiomyoma | 1.6 | 15 | Citations (PDF) |
| 394 | Clinically Relevant Characterization of Lung Adenocarcinoma Subtypes Based on Cellular Pathways: An International Validation Study | 1.5 | 47 | Citations (PDF) |
| 395 | Activation of MET by Gene Amplification or by Splice Mutations Deleting the Juxtamembrane Domain in Primary Resected Lung Cancers | 1.5 | 308 | Citations (PDF) |
| 396 | EGFR T790M Mutation: A Double Role in Lung Cancer Cell Survival? | 1.5 | 197 | Citations (PDF) |
| 397 | Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy | 1.0 | 27 | Citations (PDF) |
| 398 | Benign Metastasizing Leiomyoma of the Lung: Potential Role of Low-Grade Malignancy | 0.3 | 7 | Citations (PDF) |
| 399 | Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cells | 2.2 | 83 | Citations (PDF) |
| 400 | Impact of Multiple
Alcohol Dehydrogenase
Gene Polymorphisms on Risk of Upper Aerodigestive Tract Cancers in a Japanese Population | 0.6 | 65 | Citations (PDF) |
| 401 | Combined hepatocellular carcinoma and osteoclast‐like giant cell tumor of the liver: Possible clue to histogenesis | 0.8 | 18 | Citations (PDF) |
| 402 | Rare pancreatic neoplasms: the utility of endoscopic ultrasound-guided fine-needle aspiration—a large single center study | 3.0 | 27 | Citations (PDF) |
| 403 | Usefulness of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for undiagnosed intra-abdominal lymphadenopathy | 3.0 | 55 | Citations (PDF) |
| 404 | Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA | 3.0 | 225 | Citations (PDF) |
| 405 | Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non‐small‐cell lung cancer for gefitinib treatment | 2.9 | 16 | Citations (PDF) |
| 406 | Counterbalance between RB inactivation and miR-17–92 overexpression in reactive oxygen species and DNA damage induction in lung cancers | 5.2 | 100 | Citations (PDF) |
| 407 | hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological type | 1.3 | 53 | Citations (PDF) |
| 408 | Association between an 8q24 locus and the risk of colorectal cancer in Japanese | 2.1 | 34 | Citations (PDF) |
| 409 | Prognostic Implication of EGFR, KRAS, and TP53 Gene Mutations in a Large Cohort of Japanese Patients with Surgically Treated Lung Adenocarcinoma | 1.5 | 232 | Citations (PDF) |
| 410 | Efficacy of Erlotinib for Brain and Leptomeningeal Metastases in Patients with Lung Adenocarcinoma Who Showed Initial Good Response to Gefitinib | 1.5 | 153 | Citations (PDF) |
| 411 | EGFR and HER2 Genomic Gain in Recurrent Non-small Cell Lung Cancer After Surgery: Impact on Outcome to Treatment with Gefitinib and Association with EGFR and KRAS Mutations in a Japanese Cohort | 1.5 | 52 | Citations (PDF) |
| 412 | Clinical outcomes of advanced non-small cell lung cancer patients screened for epidermal growth factor receptor gene mutations | 1.8 | 15 | Citations (PDF) |
| 413 | Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinoma | 3.0 | 49 | Citations (PDF) |
| 414 | EGFR Mutation, But Not Sex and Smoking, Is Independently Associated with Favorable Prognosis of Gefitinib-treated Patients with Lung Adenocarcinoma | 0.1 | 0 | Citations (PDF) |
| 415 | A resected case difficult in distinguishing invasive adenocarcinoma derived from IPMN from usual pancreatic cancer coexisting with IPMN -introduction of genomic exploration- | 0.0 | 2 | Citations (PDF) |
| 416 | Chemosensitivity in Malignant Mesothelioma; Future Strategy | 0.1 | 0 | Citations (PDF) |
| 417 | Colorectal Liver Metastases Associated with Portal, Intrabiliary Tumor Thrombus and Peri-Choledochal Nodal Involvement: A Case Report | 0.1 | 1 | Citations (PDF) |
| 418 | Abstract A178: Role of tumor and host‐derived HGF in drug resistance to EGFR inhibitors in EGFR activating mutation‐positive lung cancer 2009, , | | 0 | Citations (PDF) |
| 419 | Aberrant expression of BCL2A1-restricted minor histocompatibility antigens in melanoma cells: application for allogeneic transplantation | 0.9 | 14 | Citations (PDF) |
| 420 | Stepwise examination for differential diagnosis of primary lung cancer and breast cancer relapse presenting as a solitary pulmonary nodule in patients after mastectomy | 1.2 | 14 | Citations (PDF) |
| 421 | Simultaneous comparison of multiple molecules using tissue array analysis in the thyroid neoplasm | 1.0 | 0 | Citations (PDF) |
| 422 | mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines | 2.7 | 30 | Citations (PDF) |
| 423 | Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib‐treated patients with lung adenocarcinoma | 2.9 | 37 | Citations (PDF) |
| 424 | Soy consumption reduces the risk of non‐small‐cell lung cancers with epidermal growth factor receptor mutations among Japanese | 2.9 | 30 | Citations (PDF) |
| 425 | Interleukin‐2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor‐overexpressing gastric cancer xenografts through antibody‐dependent cellular cytotoxicity | 2.9 | 42 | Citations (PDF) |
| 426 | Sarcomatoid carcinoma of the thymus arising in metaplastic thymoma | 2.6 | 28 | Citations (PDF) |
| 427 | Intraoperative diagnosis of cancer metastasis in sentinel lymph node of oral cancer patients | 1.4 | 32 | Citations (PDF) |
| 428 | Subcategorization of Lung Cancer Based on Tumor Size and Degree of Visceral Pleural Invasion | 2.6 | 23 | Citations (PDF) |
| 429 | Decreased risk of colorectal cancer with the high natural killer cell activity NKG2D genotype in Japanese | 2.2 | 52 | Citations (PDF) |
| 430 | Clinical Features and Prognosis of Gastric MALT Lymphoma With Special Reference to Responsiveness to H. pylori Eradication and API2-MALT1 Status | 0.7 | 57 | Citations (PDF) |
| 431 | YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylation | 2.2 | 98 | Citations (PDF) |
| 432 | Coincidence of Mammary and Sentinel Lymph Node Papilloma | 2.3 | 18 | Citations (PDF) |
| 433 | A 25-Signal Proteomic Signature and Outcome for Patients With Resected Non–Small-Cell Lung Cancer | 3.2 | 77 | Citations (PDF) |
| 434 | Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case–control study | 2.2 | 70 | Citations (PDF) |
| 435 | Controversy about Small Peripheral Lung Adenocarcinomas: How Should We Manage Them? | 1.5 | 15 | Citations (PDF) |
| 436 | c-Maf Expression in Angioimmunoblastic T-cell Lymphoma | 2.3 | 54 | Citations (PDF) |
| 437 | Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung Cancer | 1.5 | 75 | Citations (PDF) |
| 438 | Distribution of Intraductal Lesions in Small Invasive Ductal Carcinoma of the Pancreas | 0.8 | 17 | Citations (PDF) |
| 439 | Factors involved in lymph node metastasis in clinical stage I non-small cell lung cancer—From studies of 604 surgical cases | 1.8 | 17 | Citations (PDF) |
| 440 | A case of colonic morule with colitis cystica profunda | 1.0 | 5 | Citations (PDF) |
| 441 | Chromosomal imbalances are associated with outcome ofHelicobacter pylorieradication in t(11;18)(q21;q21) negative gastric mucosa-associated lymphoid tissue lymphomas | 1.7 | 27 | Citations (PDF) |
| 442 | Malignant adenomyoepithelioma of the breast with matrix production may be compatible with one variant form of matrix-producing carcinoma: A case report | 2.2 | 17 | Citations (PDF) |
| 443 | Disproportionate representation ofKRAS gene mutation in atypical adenomatous hyperplasia, but even distribution ofEGFR gene mutation from preinvasive to invasive adenocarcinomas | 3.2 | 128 | Citations (PDF) |
| 444 | Identification of a metastasis signature and the DLX4 homeobox protein as a regulator of metastasis by combined transcriptome approach | 5.2 | 47 | Citations (PDF) |
| 445 | Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib | 4.1 | 49 | Citations (PDF) |
| 446 | API2-MALT1chimeric transcript-positive gastroduodenal MALT lymphoma with subsequent development of adenocarcinoma as a collision tumour over a clinical course of 7 years | 2.6 | 10 | Citations (PDF) |
| 447 | Risk factors differ for non-small-cell lung cancers with and without EGFR mutation: assessment of smoking and sex by a case-control study in Japanese | 2.9 | 90 | Citations (PDF) |
| 448 | Genomic profiling of malignant pleural mesothelioma with array‐based comparative genomic hybridization shows frequent non‐random chromosomal alteration regions including JUN amplification on 1p32 | 2.9 | 88 | Citations (PDF) |
| 449 | LKB1 gene mutations in Japanese lung cancer patients | 2.9 | 52 | Citations (PDF) |
| 450 | Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer | 2.9 | 590 | Citations (PDF) |
| 451 | Development-dependent expression of cyclin D3 in precursor T-cell lymphoblastic leukemia/lymphoma | 0.8 | 8 | Citations (PDF) |
| 452 | Pure acinic cell carcinoma of the breast in an 80-year-old Japanese woman | 0.8 | 31 | Citations (PDF) |
| 453 | Epidermal growth factor receptor mutations in lung cancers | 0.8 | 77 | Citations (PDF) |
| 454 | High‐level expression of CD109 is frequently detected in lung squamous cell carcinomas | 0.8 | 55 | Citations (PDF) |
| 455 | Neuroendocrine tumor metastasis to the thyroid gland | 1.6 | 19 | Citations (PDF) |
| 456 | Osteosarcoma with skeletal muscle metastasis | 1.5 | 4 | Citations (PDF) |
| 457 | Prospective Validation for Prediction of Gefitinib Sensitivity by Epidermal Growth Factor Receptor Gene Mutation in Patients with Non-Small Cell Lung Cancer | 1.5 | 135 | Citations (PDF) |
| 458 | Molecular Pathology of the Lung Cancer -Molecular Classification of Lung Cancer Based on Expression Profile- | 0.1 | 0 | Citations (PDF) |
| 459 | A Rapid, Sensitive Assay to Detect EGFR Mutation in Small Biopsy Specimens from Lung Cancer | 1.9 | 179 | Citations (PDF) |
| 460 | Short-term development of esophageal pyogenic granuloma observed on endoscopy | 1.0 | 6 | Citations (PDF) |
| 461 | Clinicopathological Study of Intraductal Papillary-Mucinous Neoplasm (IPMN) of the Pancreas with Long-Term Follow-Up | 1.0 | 0 | Citations (PDF) |
| 462 | PTEN and PIK3CA Expression Is Associated with Prolonged Survival after Gefitinib Treatment in EGFR-Mutated Lung Cancer Patients | 1.5 | 28 | Citations (PDF) |
| 463 | PTEN and PIK3CA Expression Is Associated with Prolonged Survival after Gefitinib Treatment in EGFR-Mutated Lung Cancer Patients | 1.5 | 68 | Citations (PDF) |
| 464 | LONG-TERM FOLLOW UP OF PATIENTS WITH SMALL GASTROINTESTINAL STROMAL TUMORS IN THE STOMACH USING ENDOSCOPIC ULTRASONOGRAPHY-GUIDED FINE-NEEDLE ASPIRATION BIOPSY | 2.7 | 14 | Citations (PDF) |
| 465 | The human cathepsin H gene encodes two novel minor histocompatibility antigen epitopes restricted by HLA-A*3101 and -A*3303 | 1.7 | 38 | Citations (PDF) |
| 466 | Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasis | 4.1 | 49 | Citations (PDF) |
| 467 | Biological and clinical implications of EGFR mutations in lung cancer | 1.6 | 207 | Citations (PDF) |
| 468 | Molecular classification of tumors with special reference to EGFR mutation in lung cancer | 1.3 | 6 | Citations (PDF) |
| 469 | Immunocytochemical detection using CDX2 | 2.7 | 10 | Citations (PDF) |
| 470 | Sentinel lymph node radiolocalization in clinically negative neck oral cancer | 1.4 | 46 | Citations (PDF) |
| 471 | Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosis | 9.6 | 84 | Citations (PDF) |
| 472 | Mutations of epidermal growth factor receptor andK-rasgenes in adenosquamous carcinoma of the lung | 2.8 | 67 | Citations (PDF) |
| 473 | Expression Profile–Defined Classification of Lung Adenocarcinoma Shows Close Relationship With Underlying Major Genetic Changes and Clinicopathologic Behaviors | 12.4 | 314 | Citations (PDF) |
| 474 | EGFR mutations in patients with brain metastases from lung cancer: Association with the efficacy of gefitinib | 0.9 | 84 | Citations (PDF) |
| 475 | Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers | 3.8 | 143 | Citations (PDF) |
| 476 | Relationship Between Prognosis and Nodal Micrometastasis in Patients With Non-Small Cell Lung Cancer | 0.1 | 0 | Citations (PDF) |
| 477 | EGFR Mutation Is Specific for Terminal Respiratory Unit Type Adenocarcinoma | 2.3 | 235 | Citations (PDF) |
| 478 | Reduced expression of Dicer associated with poor prognosis in lung cancer patients | 2.9 | 593 | Citations (PDF) |
| 479 | Throwing new light on lung cancer pathogenesis: Updates on three recent topics | 2.9 | 19 | Citations (PDF) |
| 480 | Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNAB): past, present, and future | 3.0 | 118 | Citations (PDF) |
| 481 | Fulminant myocarditis demonstrating uncommon morphology?a report of two autopsy cases | 1.9 | 23 | Citations (PDF) |
| 482 | Mutations of the Epidermal Growth Factor Receptor Gene Predict Prolonged Survival After Gefitinib Treatment in Patients With Non–Small-Cell Lung Cancer With Postoperative Recurrence | 12.4 | 932 | Citations (PDF) |
| 483 | P-648 EGFR and Ki-ras mutations in pulmonary adenosquamous carcinoma | 1.8 | 0 | Citations (PDF) |
| 484 | Prognostic Model of Pulmonary Adenocarcinoma by Expression Profiling of Eight Genes As Determined by Quantitative Real-Time Reverse Transcriptase Polymerase Chain Reaction | 12.4 | 156 | Citations (PDF) |
| 485 | Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation | 5.2 | 52 | Citations (PDF) |
| 486 | Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients | 5.2 | 145 | Citations (PDF) |
| 487 | Phenotypic composition of salivary gland tumors: an application of principle component analysis to tissue microarray data | 3.8 | 18 | Citations (PDF) |
| 488 | Frequent expression of CD30 antigen in the primary gastric non-B, non-Hodgkin lymphomas | 0.8 | 16 | Citations (PDF) |
| 489 | Allelic length of a CA dinucleotide repeat in theegfr gene correlates with the frequency of amplifications of this sequence—first results of an inter-ethnic breast cancer study | 3.2 | 96 | Citations (PDF) |
| 490 | CK20 expression, CDX2 expression,K-ras mutation, and goblet cell morphology in a subset of lung adenocarcinomas | 3.2 | 88 | Citations (PDF) |
| 491 | Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patients | 2.8 | 215 | Citations (PDF) |
| 492 | Identification of MGB1 as a Marker in the Differential Diagnosis of Lung Tumors in Patients with a History of Breast Cancer by Analysis of Publicly Available SAGE Data | 1.9 | 16 | Citations (PDF) |
| 493 | Colorectal Pretumor Progression Before and After Loss of DNA Mismatch Repair | 2.8 | 25 | Citations (PDF) |
| 494 | Focal adhesion kinase is overexpressed in hepatocellular carcinoma and can be served as an independent prognostic factor | 6.7 | 104 | Citations (PDF) |
| 495 | Thyroid anaplastic carcinoma transformed from papillary carcinoma in extrathyroid area | 1.1 | 18 | Citations (PDF) |
| 496 | Effects of taurine administration in rat skeletal muscles on exercise | 1.0 | 70 | Citations (PDF) |
| 497 | RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication | 2.8 | 67 | Citations (PDF) |
| 498 | Prognostic models in patients with non-small-cell lung cancer using artificial neural networks in comparison with logistic regression | 2.9 | 32 | Citations (PDF) |
| 499 | Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancer | 5.2 | 35 | Citations (PDF) |
| 500 | The sensitivity of lung cancer cell lines to the EGFR-selective tyrosine kinase inhibitor ZD1839 (‘Iressa’11Iressa’ is a trademark of the AstraZeneca group of companies.) is not related to the expression of EGFR or HER-2 or to K-ras gene status | 1.8 | 66 | Citations (PDF) |
| 501 | Senile EBV+ B-Cell Lymphoproliferative Disorders | 2.3 | 392 | Citations (PDF) |
| 502 | TTF-1 Expression in Pulmonary Adenocarcinomas | 2.3 | 375 | Citations (PDF) |
| 503 | Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers | 5.2 | 119 | Citations (PDF) |
| 504 | Decreased expression of 14-3-3σ in neuroendocrine tumors is independent of origin and malignant potential | 5.2 | 31 | Citations (PDF) |
| 505 | Increased Expression of COX-2 in the Development of Human Lung Cancers | 1.2 | 30 | Citations (PDF) |
| 506 | Protective Function of p27KIP1 against Apoptosis in Small Cell Lung Cancer Cells in Unfavorable Microenvironments | 2.8 | 35 | Citations (PDF) |
| 507 | Dietary factors and lung cancer risk in Japanese: with special reference to fish consumption and adenocarcinomas | 4.1 | 84 | Citations (PDF) |
| 508 | Peripheral T/Natural killer-cell lymphoma involving the female genital tract: A clinicopathologic study of 5 cases | 0.9 | 33 | Citations (PDF) |
| 509 | Intraclonal microheterogeneity of mucosa-associated lymphoid tissue lymphoma with a multiple lymphomatous polyposis appearance in the gastrointestinal tract | 0.8 | 1 | Citations (PDF) |
| 510 | Morphological spectrum of cyclin D1-positive mantle cell lymphoma: Study of 168 cases | 0.8 | 45 | Citations (PDF) |
| 511 | Investigating stem cells in human colon by using methylation patterns | 5.2 | 336 | Citations (PDF) |
| 512 | Bladder cancer genotype stability during clinical progression | 1.7 | 12 | Citations (PDF) |
| 513 | Saturation transfer ratio imaging in invasive ductal carcinomas of the breast | 1.2 | 13 | Citations (PDF) |
| 514 | Helicobacter pyloriand the t(11;18)(q21;q21) Translocation in Gastric Low-grade B-Cell Lymphoma of Mucosa-associated Lymphoid Tissue Type | 1.8 | 66 | Citations (PDF) |
| 515 | Characterization of High-grade Neuroendocrine Tumors of the Lung in Relation to menin Mutations | 1.8 | 15 | Citations (PDF) |
| 516 | Immunohistochemical and Immunogenetic Analyses of Ocular Adnexal Lymphoid Proliferation | 1.4 | 3 | Citations (PDF) |
| 517 | Genetic reconstruction of individual colorectal tumor histories | 5.2 | 137 | Citations (PDF) |
| 518 | Topographical Distributions of Allelic Loss in Individual Non-Small-Cell Lung Cancers | 2.8 | 25 | Citations (PDF) |
| 519 | Non-Hodgkin's Lymphoma Followed by Plasmacytoma, Both Arising in a Thyroid Gland with Hashimoto's Disease | 1.0 | 4 | Citations (PDF) |
| 520 | Frameshift mutations in TGFβRII, IGFIIR, BAX, hMSH3 and hMSH6 are absent in lung cancers | 2.2 | 13 | Citations (PDF) |
| 521 | An autopsy case of primary nodal plasmacytoma associated with Sjogren's syndrome | 0.8 | 9 | Citations (PDF) |
| 522 | Primary low-grade gastric mucosa-associated lymphoid tissue (MALT) lymphoma with polypoid appearance. Polypoid gastric MALT lymphoma: A clinicopathologic study of eight cases | 0.8 | 22 | Citations (PDF) |
| 523 | Hodgkin disease with subsequent transformation to CD30 positive non-Hodgkin lymphoma in six patients | 2.7 | 8 | Citations (PDF) |
| 524 | A new multiple myeloma cell line, MEF-1, possesses cyclin d1 overexpression and the p53 mutation | 2.7 | 9 | Citations (PDF) |
| 525 | Hodgkin's Disease Expressing Follicular Dendritic Cell Marker CD21 Without Any Other B-cell Marker | 2.3 | 37 | Citations (PDF) |
| 526 | Nodal Cytotoxic Lymphoma Spectrum | 2.3 | 81 | Citations (PDF) |
| 527 | Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers | 5.2 | 50 | Citations (PDF) |
| 528 | Coexisting primary early gastric plasmacytoma and sarcoidosis with hypercalcaemia | 1.9 | 4 | Citations (PDF) |
| 529 | Establishment of an IL-2-dependent cell line derived from ‘nasal-type’ NK/T-cell lymphoma of CD2+
, sCD3−
, CD3ɛ+
, CD56+
phenotype and associated with the Epstein-Barr virus | 1.7 | 47 | Citations (PDF) |
| 530 | Frequency of MAGE-3 gene expression in HLA-A2 positive patients with non-small cell lung cancer | 1.8 | 31 | Citations (PDF) |
| 531 | Breast Carcinoma with Myeloid Metaplasia - A Case Report | 2.2 | 9 | Citations (PDF) |
| 532 | CD7+ and CD56+ Myeloid/Natural Killer Cell Precursor Acute Leukemia: A Distinct Hematolymphoid Disease EntityBlood, 1997, 90, 2417-2428 | 3.6 | 188 | Citations (PDF) |
| 533 | Somatic Hypermutations in the VHSegment of Immunoglobulin Genes of CDS-positive Diffuse Large B-Cell Lymphomas | 1.8 | 34 | Citations (PDF) |
| 534 | Complete cytogenetic response with host-derived hematopoiesis induced by cyclosporin A discontinuation in a patient with relapsed chronic myelogenous leukemia after bone marrow transplantation | 1.9 | 4 | Citations (PDF) |
| 535 | Immunohistochemical study of necrotizing lymphadenitis: A possible mechanism for apoptosis involving perforin and granzyme‐producing cytotoxic T cells | 0.8 | 11 | Citations (PDF) |
| 536 | Clinicopathologic study of nasal T/NK‐cell lymphoma among the Japanese | 0.8 | 88 | Citations (PDF) |
| 537 | Epstein‐Barr virus‐related Hodgkin's disease showing B cell lineage in an immunosuppressive patient seropositive for HTLV‐I | 0.8 | 9 | Citations (PDF) |
| 538 | Cyclin D1 over expression in malignant lymphomas | 0.8 | 42 | Citations (PDF) |
| 539 | Mutations of the p53 tumor suppressor gene as clonal marker for multiple primary lung cancers | 2.2 | 58 | Citations (PDF) |
| 540 | Immunohistochemical and immunogenetic analysis of ocular adenexal lymphoid proliferations | 1.4 | 0 | Citations (PDF) |
| 541 | Broncho-bronchiolitis obliterans as a complication of bone marrow transplantation: a clinicopathological study of eight autopsy cases | 1.9 | 69 | Citations (PDF) |
| 542 | A Nodal γ/δ T-cell Lymphoma with an Association of Epstein-Barr Virus | 2.3 | 23 | Citations (PDF) |
| 543 | Anaplastic Large Cell Lymphoma: A Distinct Molecular Pathologic Entity | 2.3 | 155 | Citations (PDF) |
| 544 | Chronic Active Epstein-Barr Virus Infection With Giant Coronary Aneurysms | 0.4 | 44 | Citations (PDF) |
| 545 | Mammographic and ultrasonographic findings of invasive lobular carcinoma | 1.6 | 0 | Citations (PDF) |
| 546 | Primary gastric lymphomas: Morphologic, immunohistochemical and immunogenetic analyses | 0.8 | 17 | Citations (PDF) |
| 547 | Primary hepatic marginal zone B-cell lymphoma with mantle cell lymphoma phenotype | 1.9 | 27 | Citations (PDF) |
| 548 | Pyothorax-associated Lymphoma | 2.3 | 41 | Citations (PDF) |
| 549 | Clinicopathologic Study of PRAD1/Cyclin D1 Overexpressing Lymphoma with Special Reference to Mantle Cell Lymphoma | 2.3 | 84 | Citations (PDF) |
| 550 | Mucosa‐associated lymphoid tissue (MALT) Iymphoma | 0.8 | 12 | Citations (PDF) |
| 551 | Immunohistochemical Analysis of Cyclin D1 Protein in Hematopoietic Neoplasms with Special Reference to Mantle Cell Lymphoma | 1.8 | 47 | Citations (PDF) |
| 552 | Primary gastric Ki‐1 positive anaplastic large cell lymphoma: A report of two cases | 0.8 | 15 | Citations (PDF) |
| 553 | The evolution of cancer genomic medicine in Japan and the role of the National Cancer Center Japan | 3.1 | 4 | Citations (PDF) |
| 554 | Dynamic nature of hepatic differentiation in lung adenocarcinoma | 2.6 | 2 | Citations (PDF) |
| 555 | Immunohistochemical evaluation of CREM in CREB-rearranged mesenchymal tumors and their mimics | 1.9 | 1 | Citations (PDF) |
| 556 | Nationwide Real‐World Usage of Blood‐Based (Liquid) Biomarker Testing in Japan | 2.9 | 2 | Citations (PDF) |
| 557 | FGFR2
Fusions or Rearrangements in Young Intrahepatic and Perihilar Cholangiocarcinoma Patients: Key Genetic Insights From a Pan‐Asian Study | 2.1 | 1 | Citations (PDF) |
| 558 | Unveiling the molecular and clinical risk landscape of second primary lung cancer in resected non-small cell lung cancer | 1.8 | 1 | Citations (PDF) |
| 559 | Genomic Profiles as Predictors of Occult Lymph Node Metastasis and Clinical Outcomes in Early-Stage Clinical N0 Non-Small Cell Lung Cancer | 2.1 | 1 | Citations (PDF) |
| 560 | Artificial Intelligence-Advanced Imaging for Solid-Type Lung Adenocarcinoma: Towards Greater Clinical Relevance | 1.2 | 0 | Citations (PDF) |
| 561 | Genomic Profiling of Pediatric Solid Tumors With a Dual
DNA
/
RNA
Panel:
JCCG‐TOP2
Study | 2.9 | 1 | Citations (PDF) |
| 562 | Low
OLFM1
and
BMP6
Expression Predicts Recurrence in Early-Stage Nonsquamous NSCLC with Pure Solid Tumor Appearance | 2.1 | 0 | Citations (PDF) |
| 563 | Immunohistochemical analysis of thyroid transcription factor-1 in type A and AB thymomas comparing multiple primary antibody clones | 1.2 | 0 | Citations (PDF) |
| 564 | When wedge resection is good enough: Survival outcomes and nodal involvement of ground-glass–dominant stage IA non–small cell lung cancer | 1.1 | 0 | Citations (PDF) |
| 565 | Late‐Onset Bilateral Malignant Ciliary Body Medulloepithelioma in an Adult | 0.8 | 1 | Citations (PDF) |
| 566 | Cooccurrence of myelodysplastic neoplasm and myeloid sarcoma with background mediastinal germ cell tumor: an autopsy case | 0.8 | 0 | Citations (PDF) |
| 567 | Brief Report: Low Delta-Like Ligand 3 Expression and T-Cell Exhaustion Drive Resistance to Tarlatamab Combined With Anti–Programmed Cell Death Protein 1 in SCLC | 1.5 | 2 | Citations (PDF) |
| 568 | Spatial Transcriptomics and Bulk
RNA
‐Seq Analysis Revealed Molecular Classification of Invasive Lobular Carcinoma | 2.9 | 0 | Citations (PDF) |
| 569 | AI analysis of elastin staining sections reveals the biological implications of cancer-related fibrosis in small-sized lung adenocarcinomas | 1.8 | 0 | Citations (PDF) |
